Magnusson, J.
Karlsson, J.
Sköldenberg, O.
Albert, J.
Frostell, C.
Jakobsson, J. G.
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 29 February 2024
Accepted: 19 April 2024
First Online: 15 May 2024
Declarations
:
: The study was approved by the Ethical Review Board 2022-02521-02, Uppsala department 2 of medicine.
: Jan Jakobsson is a paid safety physician for AstraZeneca, further conflict related to current manuscript, Johanna Albert and Claes Frostell are members of the SPOR board.
: The authors declare no competing interests.